Changes of leptin levels in menopause;Modificazioni dei livelli sierici di leptina in menopausa

Minerva Ginecologica

Volumn 53, Issue 3, 2001, Pages 193-198

  Tommaselli, G A ^a   Di Carlo, C ^a   Pellicano, M ^a   Nasti, A ^a   Ferrara, C ^a   Di Spiezio Sardo, A ^a   Nola, B ^a   Nappi, C ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Body composition; Leptin; Menopause

Indexed keywords

ESTROGEN; LEPTIN;

ADULT; AGE; ANIMAL; BLOOD; BODY COMPOSITION; BODY WEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; ESTROGEN THERAPY; FEMALE; HUMAN; MALE; MENOPAUSE; MIDDLE AGED; OVARIECTOMY; PHYSIOLOGY; POSTMENOPAUSE; RAT; REPRODUCTION; REVIEW; SEX DIFFERENCE;

ADULT; AGE FACTORS; ANIMALS; BODY COMPOSITION; BODY WEIGHT; CLINICAL TRIALS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; LEPTIN; MALE; MENOPAUSE; MIDDLE AGED; OVARIECTOMY; POSTMENOPAUSE; RATS; REPRODUCTION; SEX FACTORS;

EID: 0035374368     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bray GA, York DA. Leptin and clinical medicine: a new piece in the puzzle of obesity. J Clin Endocrinol Metab 1997;82:2771-6.
2. Kaira SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetide-regulating pathways in the hypothalamic regulation of body weight. Endocrine Rev 1999;20:68-100.
3. Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978;14:141-8.
4. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372: 425-32.
5. Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M et al. Human obese gene epression: adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995;44:855-8.
6. Madej T, Boguski MS, Buyaub SM. Threadly analysis suggests that the obese gene product may be a helical cytokine. FEBS Letters 1995;373:13-8.
7. Sinha M, Opentanova I, Ohannesian JP, Kolaczynki JV, Heiman ML, Hale J et al. Evidence of free and bound leptin in human circulation: studies in lean and obese subjects and during short-term fasting. J Clin Invest 1996;98:1277-82.
8. Campfield LA, Smith FJ, Burn P. The OB protein (leptin) pathway. A link between adipose tissue mass and central neural networks. Horm Metab Res 1996;28:619-32.
9. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1995;1:1155-61.
10. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. Serum immunoreactive-leptin concentrations in normal-weight and obese human. N Engl J Med 1996;334:2-5.
11. Caro JF, Kolaczynsli JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH et al. Decreased cerebrospinal-fluid serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996;348: 159-61.
12. Wettstein JG, Earley B, Junien JL. Central nervous system pharmacology of neuropeptide Y. Pharmacol Ther 1995;65:397-414.
13. Lonnqvist F, Arner P, Nordfors L, Schalling. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nature Med 1995;9:950-3.
14. Hamilton BS, Paglia D, Kwan AYM, Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nature Med 1995;9:953-6.
15. Swerdloff RS, Batt RA, Bray GA. Reproductive hormonal function in the genetically obese (ob/ob) mouse. Endocrinology 1994;98:1359-64.
16. Chehab FF, Lim ME, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with human recombinant leptin. Nature Gen 1996;12: 318-20.
17. Barash IA, Cheung CC, Weigle DS, Ren H, Kabigting EB, Kuijper JL et al. Leptin is a metabolic signal to the reproductive system. Endocrinology 1996;137:3144-7.
18. Yu WH, Walczewska A, Karanth S, McCann SM. Role of leptin in hypothalamic-pituitary function. Proc Natl Acad Sci USA 1997;94:1023-8.
19. Cioffi JA, Shafer AW, Zupancic TJ, Smith-Gbur J, Mikhail A, Platika D et al. Novel B219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction. Nature Med 1996;2:585-9.
20. Karlsson C, Lindell K, Svensson E, Bergh C, Lind P, Billig H et al. Expression of functional leptin receptors in the human ovary. J Clin Endocrinol Metab 1997;82:4144-8.
21. Catzeflis C, Pierroz DD, Rohner-Jeanrenaud F, Rivier JE, Sizonenko PC, Aubert ML. Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in the intact adult female rats. Endocrinology 1993;132:224-34.
22. Pierroz DD, Catzeflis C, Aebi AC, Rivier JE, Aubert ML. Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats. Endocrinology 1996;137: 3-12.
23. Havel PJ, Kasim-Karakas S, Dubuc GR, Mueller W, Phinney SD. Gender differences in plasma leptin concentrations. Nature Med 1996;2:949-50.
24. Rosenbaum M, Nicolson M, Hirsch J, Heysfield SB, Gallagher D, Chu E et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996;81:3424-7.
25. Haffner SM, Mykkanen L, Stern MP. Leptin concentrations in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy. Am J Epidemiol 1997;146:581-5.
26. Shimizu H, Shimomura Y, Nakanishi Y, Futawatari T, Ohtani K, Sato N et al. Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol 1997;154:285-92.
27. Khort WM, Landt M, Birge SJ Jr. Serum leptin levels are reduced in response to exercise training but not hormone replacement therapy, in older women. J Clin Endocrinol Metab 1996;81:3980-5.
28. Moller N, O'Brien P, Nair KS. Disruption of the relationship between fat content and leptin levels with aging in humans. J Clin Endocrinol Metab 1998;83: 931-4.
29. Nicklas BJ, Toth MJ, Goldberg AP, Poehlman ET. Racial differences in plasma leptin concentration in obese postmenopausal women. J Clin Endocrinol Metab 1997;82:515-7.
30. Di Carlo C, Tommaselli GA, Pisano G, Nasti A, Rossi V, Palomba S et al. Serum leptin levels in postmenopausal women: effects of transdermal hormonal replacement therapy. Menopause (In press.).
31. The writing group for the PEPI trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273: 199-208.
32. Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, Orlandi R et al. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 1997;82:414-7.
33. Burger HG, Dudley EC, Hopper JL, Shelly JM, Green A, Smith A et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab 1995;80:3537-45.
34. Forbes GB, Reina JC. Adult lean body mass declines with age: longitudinal observations. Metabolism 1970;19:653-63.
35. Espeland MA, Stefanick MI, Kritz-Silverstein D, Fineberg SE, Waclawiw MA, James MK et al. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. J Clin Endocrinol Metab 1997;82: 1549-56.
36. Hassager C, Christiansen C. Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women. Metabolism 1989;38:662-5.